Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Vertex Pharmaceuticals (VRTX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2023 Q4 | 812 | 0.01 | Reduce 44.27% | <0.01 | $406.89 | $330,395 | SEC |
| 2023 Q3 | 1,457 | 0.01 | Buy | 0.01 | $347.74 | $506,657 | SEC |
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2021 Q3 | 18,052 | 0.03 | Buy | 0.03 | $181.36 | $3,274,000 | SEC |
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2021 Q1 | 6,254 | 0.01 | Buy | 0.01 | $214.90 | $1,344,000 | SEC |
| 2020 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2020 Q1 | 460 | <0.01 | Buy | <0.01 | $236.96 | $109,000 | SEC |
| 2015 Q2 | 0 | 0.00 | Sell 100.00% | 1.06 | SEC | ||
| 2015 Q1 | 524,867 | 1.06 | Buy | 1.06 | $117.97 | $61,919,000 | SEC |